A Guide to State Licensing for Virtual Manufacturers

Virtual manufacturers are becoming increasingly common in the pharmaceutical industry.

These companies bring products to market while relying on contract partners to perform key functions such as manufacturing, packaging, storage, and distribution.

Although these operations are outsourced, virtual manufacturers remain fully responsible for regulatory compliance, product quality, and supply chain oversight.

What Is a Virtual Manufacturer?

A virtual manufacturer is an entity that markets and owns a drug or device, including its regulatory approvals and product specifications, while outsourcing operational activities such as manufacturing, packaging, and labeling to Contract Manufacturing Organizations (CMOs), and storage and distribution to Third-Party Logistics Providers (3PLs).

Even if the company never physically handles the product, it retains full legal and regulatory responsibility for its safety, quality, and compliance.

At the federal level, the FDA recognizes virtual manufacturers within the broader definition of a manufacturer under Section581(10) of the Federal Food, Drug, and Cosmetic Act (FD&C Act).

Although they do not directly produce products, they are considered manufacturers because they hold approved New Drug Applications (NDAs) or Abbreviated New Drug Applications (ANDAs) and maintain ultimate responsibility for products brought to market.

Regulatory Complexity in Licensing Virtual Manufacturers Across State Systems

Virtual manufacturers face significant licensing complexity because state boards of pharmacy do not regulate them uniformly. Some states do not formally define virtual manufacturers, while others require a manufacturer license or, in certain cases, a wholesale distributor license.

As a result, determining the correct license type, and whether a license is required at all, varies significantly by jurisdiction.

For example, Colorado does not recognize or license virtual manufacturers, Idaho provides a formal definition and licensing pathway, Arizona licenses them as manufacturers, and Montana regulates them as wholesale distributors.

Controlled substances add another layer of complexity. In some states, virtual manufacturers may not need a controlled substance registration if they do not physically possess or handle regulated substances. This inconsistency across jurisdictions creates additional uncertainty in determining licensing and registration obligations.

The Title Model: A Supply Chain Structure Impacting Licensing

The Title Model (sometimes referred to as the 3PL Title Model) is a distribution arrangement in which a third-party logistics (3PL) provider temporarily assumes legal ownership of physical inventory on behalf of a virtual manufacturer. This structure can help accelerate product commercialization and market entry because it eases, but does not eliminate, the licensing burden by about 75% for non-controlled, prescription drug virtual manufacturers, taking it from roughly 38 states to 8 states.

However, Title Model can be exceedingly expensive, as 3PL’s may charge anywhere from 0.5% to 3% of revenue; which may be millions of dollars in the first year if it’s a successful product launch.

Learn more about states that require licensing based on the company name simply appearing on a product label in this article: When Your Name on the Label Becomes a License Requirement

Regulatory Prerequisites

Before applying for individual state licenses, several foundational requirements should typically be in place.

Most states expect virtual manufacturers to hold a home state license (or formal confirmation from the relevant authority that no license is required) and to have FDA-approved products.

States also assess operational readiness. This generally includes having a designated responsible person or compliance representative and maintaining approved standard operating procedures (SOPs).

In some jurisdictions, additional prerequisites extend to the licensing status of supply chain partners. Certain state boards of pharmacy require Contract Manufacturing Organizations (CMOs) and Third-Party Logistics Providers (3PLs) to be properly licensed or registered within the state before a virtual manufacturer can qualify for licensure.

Common License Application Requirements for Virtual Manufacturers

While requirements vary by state, most applications request a similar set of core documentation to verify eligibility and compliance:

• Corporate formation documents – Articles of Incorporation, operating agreements, and Certificate of Good Standing
• Federal tax identification – Employer Identification Number (EIN)
• Ownership and structure disclosures – including parent companies, affiliates, and responsible officers
• Key personnel information – designated representatives, officers, and owners, often including background checks or fingerprinting
• Product listings – full inventory of prescription and/or non-prescription products
• Facility inspection records – recent inspection reports, typically within the past 12–36 months, depending on the state
• Surety bond – where required for regulatory compliance
• Business authorization – proof of active registration with the Secretary of State
• Registered agent details – authorized contact for legal and regulatory correspondence

High-Scrutiny Jurisdictions

Some state pharmacy boards impose stricter requirements due to heightened regulatory oversight and supply chain accountability.

• California requires nonresident wholesale licensing even for gray-area virtual models and enforces strict compliance expectations, including background checks and product pedigree tracking.
• Alabama has highly document-intensive requirements, including detailed contract documentation with CMOs and 3PLs, along with drug labeler information.
• Arizona places strong emphasis on supply chain verification, requiring proof that contract manufacturers are properly licensed and may block applications if CMOs are noncompliant.

Avoiding Application Delays

Common causes of application delays include incomplete submissions, slow responses to regulator deficiency requests, and inconsistencies between submitted documentation and actual business operations.

To improve outcomes, virtual manufacturers should ensure proper license classification, prepare facilities in advance for inspections when required, designate a single point of regulatory contact, and conduct a thorough final review of all application materials prior to submission.

Delays are most often caused by:

• Incomplete submissions
• Slow responses to deficiency notices
• or unclear descriptions of the business model

How to avoid licensing application delays:

• Confirm you are applying for the correct license type
• Review the full application before starting
• Keep all application details consistent across the application and documents
• Complete every field and double-check check no section is blank
• Double-check that you have all the required documents
• Ensure SOPs are accurate and match actual operations
• Prepare the facility for inspection early (*If applicable)
• Assign one knowledgeable point of contact
• Track and respond to board requests promptly
• Apply well ahead of planned operations
• Verify you are submitting the most current application form
• Perform a final quality review before submission

Navigating the Path Forward

State licensing for virtual manufacturers is anything but straightforward. The absence of a uniform regulatory frame work means that determining the correct license type, meeting prerequisite requirements, and submitting complete applications demands careful, jurisdiction-by-jurisdiction research. With the right preparation, understanding your business model's regulatory footprint, aligning your documentation, and anticipating the demands of high-scrutiny states, means virtual manufacturers can build a compliant licensing foundation that supports long-term growth and market access.

Are you a virtual manufacturer looking for assistance with state licensing?

LighthouseAI specializes in helping virtual manufacturers navigate the complexity of state licensing requirements. If you’d like professional support or consulting: Contact us today